Clinical Trial

Study Comparing Two Administration Pathways for Adenosine During Microvascular Function Assessment

Study acronym: ASPERA-ANOCA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to investigate the agreement and reproducibility between intravenous and intracoronary adenosine administration during invasive assessment of microvascular function. Goals of this study are: 1. Agreement and reproducibility between intravenous and intracoronary adenosine administration in the IMR (Index of microvascular resistance) value. 2. Agreement and reproducibility of FFR(fractional flow reserve), CFR (coronary flow reserve), MRR (microvascular resistance reserve), RRR (resistive reserve ratio) and reproducibility of each of these as compared with CFRabs (absolute coronary flow). 3. Time required for IMR measurements
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-02-13; most recent amendment 2024-10-06.
Trial Details
NCT Number NCT06269874
Lead Sponsor Johannes Gutenberg University Mainz
Conditions Microvascular Coronary Artery Disease
Enrollment 40 participants
Start Date 2027-03-02
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-08